CD34 and acute myeloid leukemia: Proteins of the so-called multi drug resistant (MDR) group, such as MDR1, BCRP, MDR3, MRP1 (also known as CD9), or LRP [46], are also heterogeneously expressed in AML with higher expression levels in CD34+CD38−CD123+ LSC.